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SUMMARY
RP2 mutations cause a severe form of X-linked retinitis pigmentosa (XLRP). The mechanism of RP2-associated retinal degeneration in
humans is unclear, and animal models of RP2 XLRP do not recapitulate this severe phenotype. Here, we developed gene-edited isogenic
RP2 knockout (RP2 KO) induced pluripotent stem cells (iPSCs) and RP2 patient-derived iPSC to produce 3D retinal organoids as a human
retinal diseasemodel. Strikingly, the RP2 KO and RP2 patient-derived organoids showed a peak in rod photoreceptor cell death at day 150
(D150) with subsequent thinning of the organoid outer nuclear layer (ONL) by D180 of culture. Adeno-associated virus-mediated gene
augmentation with human RP2 rescued the degeneration phenotype of the RP2 KO organoids, to prevent ONL thinning and restore
rhodopsin expression. Notably, these data show that 3D retinal organoids can be used tomodel photoreceptor degeneration and test po-
tential therapies to prevent photoreceptor cell death.
INTRODUCTION
The reprogramming of patient-derived cells into induced
pluripotent stem cells (iPSCs) has enabled the derivation
and differentiation of a range of somatic cell types and
has revolutionized our ability to study inherited disease
(Takahashi et al., 2007). The differentiation of iPSCs toward
retinal lineages has seen huge advances in recent years with
the refinement of protocols for the generation of 3D retinal
organoids (ROs) (Gagliardi et al., 2019; Nakano et al.,
2012). Unlike previous models in 2D, these 3D structures
contain photoreceptors with morphologically identifiable
features; including, inner segments rich in mitochondria,
rudimentary outer segments with connecting cilia, and
synaptic pedicles, in addition to bipolar, Müller glia, gan-
glion and amacrine cells, synaptic layers, and an outer
limiting membrane (OLM), arranged in retinal layers (re-
viewed in Capowski et al., 2019). These advanced models
have proven to have many translational research applica-
tions, including transplantation studies (Gonzalez-Cor-
dero et al., 2017; Shirai et al., 2016), retinal disease
modeling, and testing the efficacy of potential therapies
in human photoreceptor cells (Deng et al., 2018; Parfitt
et al., 2016; Schwarz et al., 2017; Sharma et al., 2017). To
date, however, they have not been used to model and
rescue photoreceptor cell death.
Mutations in RP2 account for approximately 15% of all
cases of X-linked retinitis pigmentosa (XLRP) (Breuer
et al., 2002; Hardcastle et al., 1999). RP2 is a GTPase-acti-
vating protein (GAP) for the small GTPase ARL3 (Veltel
et al., 2008), which is also regulated by its guanine nucleo-
tide exchange factor (GEF) ARL13B (Gotthardt et al., 2015).
ARL13B is localized to the ciliary axoneme, whereas a pool
of RP2 and ARL3 localize at the basal body and associated
centriole at the base of photoreceptors (Evans et al., 2010;
Grayson et al., 2002). ARL3, with its effectors (UNC119
and PDEdelta [PDED]) and GAP RP2, are thought to be
important in the retina to traffic lipidated proteins, such
as transducin, GRK1, and PDE6, to the photoreceptor outer
segment (Ismail et al., 2011; Schwarz et al., 2012; Wright
et al., 2011; Zhang et al., 2011; Zhang et al., 2015). Rp2
knockout mice have a relatively mild phenotype compared
with human disease. In one model mis-localization/
absence ofGRK1 and cone PDE6awas evident at 14months
(Zhang et al., 2015), whereas another model was reported
to have rhodopsin and M opsin mis-localization at
2 months and outer nuclear layer (ONL) thinning at
5 months (Li et al., 2013). In contrast, the human pheno-
type is relatively severe with some patients experiencing
macular atrophy in childhood (Jayasundera et al., 2010),
highlighting the necessity for human retinal models of
disease.
Currently there are no treatments for this condition, so
there is a need to develop potential therapies. Characteriza-
tion of iPSC-derived RPE and early-stage ROs from an indi-
vidual carrying a nonsense mutation in RP2 (c.358C > T,
p.R120X) showed changes in Golgi cohesion, Gbeta traf-
ficking in RPE, and ciliary trafficking of KIF7 in ROs
(Schwarz et al., 2015, 2017). Furthermore, treatment with
the readthrough drugs, G418 and/or Ataluren (PTC124),
Stem Cell Reports j Vol. 15 j 1–13 j July 14, 2020 j ª 2020 The Author(s). 1
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Please cite this article in press as: Lane et al., Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids, Stem
Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.05.007
could restore detectable full-length RP2 protein and rescue
the Golgi cohesion and Gbeta mis-localization in iPSC-RPE
and kinesin traffic in ROs. Gene therapy for other inherited
retinal diseases using adeno-associated viruses (AAVs) has
been shown to efficiently transduce photoreceptors and
RPE following subretinal injection (Sarra et al., 2002) in an-
imalmodels. There is a Food andDrug Administration- and
European Medicines Agency-approved AAV-mediated
ocular gene therapy (Russell et al., 2017), and a number
of AAV-mediated ocular gene therapies are currently in
phase I/II and III clinical trials (clinicaltrials.gov). AAV de-
livery of human RP2 to a mouse knockout model of RP2-
XLRP preserved cone function, but had no effect on rod
cell function and toxicity was observed at a higher viral
dose (Mookherjee et al., 2015).
Here, we describe the temporal maturation of CRISPR
gene-edited RP2 knockout ROs relative to their isogenic
control, in addition to ROs derived from two unrelated in-
dividuals with the same R120X nonsense mutation. These
studies reveal that the loss of RP2 leads to rod photore-
ceptor degeneration that can be rescued by AAV delivery
of RP2.
RESULTS
RP2 Knockout and RP2 Patient iPSCs Develop Mature
ROs
Fibroblasts from two unrelated individuals (R120X-A and
R120X-B) carrying the nonsense mutation c.358C > T;
p.R120X were reprogrammed into iPSCs by nucleofection
(Okita et al., 2011; Schwarz et al., 2015). CRISPR/Cas9
with guides designed to target exon 2 of RP2 were used to
generate RP2 knockout iPSCs using a simultaneous reprog-
ramming and gene-editing protocol (Howden et al., 2015).
The location of the gRNA on exon 2 was selected due to its
proximity to the c.358C > T p.R120X site, thus any
knockout lines generated would closely mimic the conse-
quences of this nonsense mutation. RP2 KO iPSC clones
were identified through non-homologous end-joining-
mediated creation of indels; one clone with an 8-bp dele-
tion in exon 2 of RP2 (RP2 c.371_378delAAGCTGGA;
p.Lys124SerfsTer11) was selected for further study as it
had the shortest frameshift extension before a premature
stop codon. Western blotting of iPSCs showed efficient
knockout, as no RP2 protein was detectable (Figures 1A
and 1B).
The RP2 KO line, the non-edited isogenic control, and
two R120X patient iPSC lines were differentiated into
ROs over a period of 4–10months usingmethods described
previously (Nakano et al., 2012; Zhong et al., 2014) with
slight modifications. Both methods produced biologically
similar organoids that were developmentally and structur-
ally comparable at the time points tested. By day 180
(D180) a transparent ONL with a brush-like border was
visible by light microscopy (Figure 1C). Scattered
rhodopsin-positive cells were first detectable in control or-
ganoids in the recoverin-positive ONL from D150 then
increased in number over time as the ROs matured up to
D180 (Figure S1A). By D180 all cell lines were able to
generate ROs consisting of a laminated structure with a
compacted ONL containing recoverin and cone arrestin-
positive photoreceptors (Figure 1D), above an inner nu-
clear layer (INL) containing protein kinase C alpha
(PKCa)-positive bipolar cells and CRALBP/Nestin-positive
Müller glia (Figure S1B). In all ROs, the ONL terminated
at the apical edge, with anOLM that was strongly immuno-
reactive for F actin (Figure 1D). Above the OLM, mitochon-
dria (immunoreactive for TOM20) were enriched in glob-
ular inner segments. Immunostaining for the ciliary
marker ARL13B and polyglutamylated tubulin (GT335) re-
vealed the bulging shape at the tip of the photoreceptor
connecting cilia, as they matured to form outer segment
(OS) like structures from D150 onward (Figure S1C). RP2
could be detected in control ROs at the plasma membrane
in all cells in the INL and ONL. In RP2 KO and R120X cell
lines, RP2 immunoreactivity was absent by immunocyto-
chemistry (ICC), although some background fluorescence
was observed at the edges of the presumptive OS. qPCR
was used to measure relative RP2 mRNA expression in
ROs at D180. The RP2 KO clone had only 20% RP2
mRNA relative to its isogenic control, similar to the
R120X patient ROs (n = 3) (Figure 1E), suggesting that the
mutant allele transcript is subject to nonsense-mediated
decay in all these ROs. Electron microscopy confirmed
the presence of membranous-rich structures at the apical
ciliary tip, reminiscent of early OS formation, in both con-
troland RP2 KO ROs (Figure 1F). These rudimentary OS
were often found detached from the body of the RO indi-
cating the flexibility, or fragility, of these structures in the
absence of RPE. Collectively, these results show that RP2
ablation does not prevent the differentiation of iPSC into
photoreceptors bearingOS-like structures in 3DRO culture.
Loss of RP2 Leads to Photoreceptor Cell Death and
ONL Thinning
Similar to the neural retina in vivo, the outermost cell layer
of the ROs consists of a uniform compacted ONL, which
terminates with photoreceptor synaptic pedicles that are
separated from the inner retinal cells by a layer immunore-
active for synaptic structural protein Bassoon in the outer
plexiform layer (Figure 2A). A reduction in the number of
photoreceptor nuclei in the ONL, and thereby thickness,
in vivo is a marker of photoreceptor cell degeneration.
Therefore, ONL thickness was measured in isogenic con-
trols and RP2 KO at D120, D150, and D180 (Figure 2B).
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In control ROs, the average ONL thickness increased be-
tween D120 and D150 from 20 to 25 mm, then did not
change significantly between D150 and D180. In contrast,
in RP2 KO ROs the average ONL thickness decreased signif-
icantly between D150 and D180 (p = 0.02). Similarly,
R120X ROs from both patients had significantly thinner
ONLs at D180 compared with the control cell line (p %
0.01; Figures 2 and S2). This suggested that photoreceptor
cell death might be occurring between D150 and D180 in
the RP2 null cell lines.
To test this hypothesis further, wemeasured TUNEL reac-
tivity across the ONL in RP2 KO and control ROs at D120,
D150, andD180 (Figures 2C and 2D). A small percentage of
TUNEL-positive nuclei were detectable in the photore-
ceptor ONL at all time points. In control ROs, TUNEL reac-
tivity was not significantly different at D120, D150, or
Figure 1. Retinal Organoids from R120X, RP2 KO, and Isogenic Control iPSCs
(A) Sanger sequence trace of edited RP2 KO iPSCs. CRISPR/Cas9 gene editing was used to create an 8-bp deletion in exon 2 of RP2 by NHEJ.
(B) Western blot and immunocytochemistry (ICC) of control and RP2 KO iPSC. Scale bar, 50 mm.
(C) Retinal organoid morphology at D180, a layer of IS/OS is visible by differential interference contrast above the transparent ONL. Scale
bar, 50 mm.
(D) ICC of retinal organoids at D180. Photoreceptors (recoverin and cone arrestin [coneArr]), outer limiting membrane (OLM, F actin)
mitochondria (Tom20), and connecting cilia/OS (GT335) expression in the ONL of control and RP2 null iPSC retinal organoids. RP2 is
expressed at the plasma membrane of cells in the ONL and inner nuclear layer (INL) in control organoids. Scale bar, 10 mm.
(E) qPCR of RP2 mRNA in whole retinal organoids at D180 (n = 3 independent organoids). Mean ± standard error of the mean (SEM).
(F) Electron micrographs of control and RP2 KO retinal organoids at D180. Scale bars, 5 mm (left), 1 mm (right).
Stem Cell Reports j Vol. 15 j 1–13 j July 14, 2020 3
Please cite this article in press as: Lane et al., Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids, Stem
Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.05.007
(legend on next page)
4 Stem Cell Reports j Vol. 15 j 1–13 j July 14, 2020
Please cite this article in press as: Lane et al., Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids, Stem
Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.05.007
D180. Whereas, the RP2 KO ROs had a significantly higher
percentage of TUNEL-positive cells in the ONL at D150.
There was no significant difference between RP2 KO and
controls at D120 or D180, suggesting a peak of cell death
during photoreceptor differentiation and maturation
around D150 in RP2-deficient cell lines. This was
confirmed in R120X-A ROs, with an increase in TUNEL
reactivity atD150,whichhad resolved byD180 (Figure 2D).
These data show that there is a peak in photoreceptor cell
death that correlates with their maturation and the time
course of increased rhodopsin expression.
Gene Expression Changes Associated with Loss of RP2
To investigate gene expression changes that might be asso-
ciated with the death of photoreceptors in the RP2 null or-
ganoids, RNA sequencing (RNA-seq) was performed on
D150 controls, RP2 KO, and R120X-A ROs. Principal-
component analyses and sample to sample distance shows
that the gene expression profiles of the RP2 KO ROs were
between the R120X-A patient line and the parental
isogenic control (Figures 2E and 2F). There were 328 shared
differentially expressed (DE) genes between the RP2 KO
and R120X ROs compared with control (Figures 2G–2I).
By contrast there were 651 and 813 DE genes between con-
trol and RP2 KO and R120X-A ROs, respectively, that were
not shared. Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway analyses of the shared DE genes revealed
that the ‘‘p53 signaling pathway’’ was the major upregu-
lated pathway, whereas the major downregulated pathway
was ‘‘axon guidance’’ (Figures 2J and 2K). KEGG pathway
analyses of the axon guidance-related changes showed
that expression of genes in pathways that stimulate axon
outgrowth, attraction, and repulsion were reduced (Fig-
ure S3). Whereas further investigation of the KEGG
apoptosis and p53 signaling pathways showed that a num-
ber of pro-apoptotic genes, such as p21, BAX, and PUMA,
were upregulated in both RP2 null ROs (Figure S3), support-
ing the observation that loss of RP2 induces cell death
in ROs.
Rod Photoreceptor Differentiation and Survival Is
Compromised in RP2 KO and R120X ROs
To identify which types of photoreceptor cells were most
affected by the loss of RP2, rods and cones were stained
with rhodopsin and cone arrestin at D180 (Figure 3A).
Strikingly, in the RP2 KO ROs, there was reduced immuno-
reactivity for rhodopsin compared with isogenic controls.
Unlike recoverin expression, which was widespread in
the RP2 KO ROs, rhodopsin was restricted to patches of
the ONL. To assess photoreceptor gene expression, we
quantified rhodopsin (RHO) and rod transducin (GNAT1)
expression by qPCR. In the controls both RHO and
GNAT1 showed an age-dependent increase, with a major
increase between D150 and D180. In contrast, the RP2
KO ROs had reduced expression of RHO and GNAT1
mRNA at D180, but not D120 or D150, confirming that
this difference manifested from D150 onward. The per-
centage of photoreceptors that were immunoreactive for
rhodopsin was quantified as a percentage of DAPI-positive
nuclei across the full length of the ONL in sections from all
ROs (Figure 3C). The controls showed an increase in
rhodopsin-positive cells as the ROs matured. Despite varia-
tion between individual ROs, there was a significant differ-
ence in the percentage of rhodopsin-expressing cells in
mature ROs (D180) between the isogenic control and RP2
KO cell lines (Figures 3A and 3C). Furthermore, the two
R120X lines also showed very few rhodopsin-positive pho-
toreceptors at D180, similar to the RP2 KO ROs (Figure 3C).
By contrast, the percentage of cone arrestin-positive cells
was significantly increased in the RP2 KO and R120X ROs
compared with controls at D180, and the mRNA (ARR3)
was also increased in the RP2 KO ROs at D150 and D180
Figure 2. Photoreceptor Differentiation-Associated Cell Death in RP2 KO Organoids
(A) ICC of control and RP2 KO retinal organoids showing reduced ONL thickness in RP2 KO. Recoverin staining demarcates the ONL ter-
minating in the synaptic layer stained with Bassoon. Scale bar, 10 mm.
(B) Mean ONL thickness per organoid was measured from tilescans of cryosections of a whole organoid at D120, D150 (n = 5 control; n = 4
RP2 KO at both time points), and D180. Significant ONL thinning was recorded at D180 in RP2 KO (n = 9 independent organoids) and R120X
lines (n = 3 R120X A organoids, n = 9 R120X B organoids), but not in controls (n = 10 independent organoids; p % 0.01; mean ± SD).
(C) TUNEL reactive nuclei (arrows) in the ONL of RP2 KO and isogenic control organoids at D150. Scale bar, 10 mm.
(D) Quantification of TUNEL reactivity. RP2 KO organoids had a significantly higher proportion of TUNEL-positive cells at D150 (n = 5
independent organoids p% 0.05, mean ± SD) but not at D120 (n = 3 control; n = 4 RP2 KO) or D180 (n = 5 control; n = 6 RP2 KO). R120X
organoids also had increased TUNEL reactivity at D150 (n = 5 at D150 n = 2 at D180 independent organoids).
(E) Principal-component analyses of RNA-seq data from ROs (n = 3 control and R120X A, n = 2 RP2 KO independent organoids).
(F) Sample to sample distance between samples.
(G) Venn diagram showing differentially expressed genes between RP2 KO and control and R120X and control and common genes.
(H) Heatmap showing upregulated clusters of differentially expressed genes (blue, lower expression; yellow, higher expression).
(I) Heatmap of downregulated clusters of differentially expressed genes.
(J) KEGG pathway analyses of upregulated genes.
(K) KEGG pathway analyses of downregulated genes.
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(Figure S4), suggesting that the defect primarily affects rods
and not cones. There was no significant difference in bipo-
lar cell numbers (Chx10/PKCa) between control and RP2
KO ROs (Figure S4). To exclude that these differencesmight
be attributed to simply a delay in the rate of maturation be-
tween the cell lines, control and RP2 KO ROs were main-
tained in culture for a further 120 days to D300. The RP2
KO had fewer rhodopsin-positive cells relative to the con-
trol ROs at D300, whereas recoverin-positive photorecep-
tors were maintained (Figure 3E).
AAV2/5 Efficiently Transduces ROs to Augment RP2
Expression in RP2 Null Photoreceptors
AAVs are able to transduce post-mitotic rods and cones in
mice following subretinal injection (Sarra et al., 2002)
and in iPSC-derived rod and cone photoreceptors in
ROs with varying efficiency (Gonzalez-Cordero et al.,
2018). To assess the ability of AAVs to deliver RP2 to defi-
cient photoreceptors, RP2 KO ROs were transduced with
AAV2/5.CAGp.RP2 (Figure 4A) at D140, before the
observed onset of ONL thinning, and harvested at
D180. At D180, RP2 protein could be detected by ICC
throughout the ONL (Figure 4B). At higher magnifica-
tion, the RP2 signal was detected on the plasma mem-
brane of photoreceptors (Figure 4C). The percentage of
RP2-positive cells was determined by scoring nuclei
with closely adjacent RP2 signal on the plasma mem-
brane that matched that cell morphology. The transduc-
tion efficiency was 90% ± 7% in the ONL (Figure 4D).
This included both rhodopsin-positive rod cells
Figure 3. Reduced Number of Rod Cells in RP2 KO and R120X Patient Retinal Organoids
(A) ICC of retinal organoids. Low (upper panel) and high (lower panel) power magnification of recoverin, rhodopsin, and cone arrestin
immunoreactivity in the ONL at D180 in control, RP2 KO, and R120X RP2 retinal organoids. Scale bars, 50 mm and 10 mm.
(B) RHO and GNAT1 levels in retinal organoids. qPCR showing relative fold change in mRNA in control and RP2 KO retinal organoids at D120,
D150, and D180 (n = 3, 3, 4 independent organoids). Mean ± SEM.
(C) Quantification of rhodopsin-positive cells as a percentage of ONL in control, RP2 KO and R120X patient cell lines from D120 to D180 of
differentiation. Each data point represents the mean of 1 independent organoid, counts are from tilescans of whole organoid cross-
sections (D120 n = 2 control, n = 2 RP2 KO; D150 n = 5 control, n = 6 RP2 KO; D180 n = 12 control, n = 11 RP2 KO, n = 3 R120X A, n = 5 R120X
B; **p % 0.01; mean ± SD).
(D) High and low magnification of control and RP2 KO organoids at D300 of differentiation stained with recoverin and rhodopsin. Scale
bars, 10 mm (upper panel) and 100 mm (lower panel).
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(Figure 4E) and cone arrestin-positive cone cells (Fig-
ure 4E). Sporadic RP2 staining in the inner retinal layers
was also visible, suggesting that a small proportion of the
AAV is able to penetrate the RO and transduce inner
retinal cells (Figure S5). Analysis of mRNA levels by
qPCR revealed an average 55-fold increase in RP2 tran-
script relative to control organoids (Figure 4F).
AAV2/5-Driven RP2 Gene Augmentation Improves
Photoreceptor Survival
To investigate if the increase in RP2 levels was altering
the degenerative phenotype of the ROs, ONL thickness
and rhodopsin immunoreactivity were compared in RP2
AAV-transduced versus untransduced RP2 KO ROs at
D180 (Figures 5A and 5C). The ONL was stained with
Figure 4. AAV2/5 RP2 Efficiently Transduces Rod and Cone Photoreceptors
(A) Schematic of AAV construction. CAG promoter (blue); RP2 CDS (green); RP2 30 UTR (teal); pA (red, minimal rabbit b globin poly A); ITR
(orange).
(B) RP2 expression in RP2 KO retinal organoids after transduction. ICC on RP2 KO retinal organoid cryosections 6 weeks after transduction
with AAV2/5 CAG RP2 showing RP2 expression across the photoreceptor layer (ONL). Scale bar, 50 mm.
(C) High-power magnification of RP2 immunoreactivity. Scale bar, 10 mm.
(D) Cells with RP2 immunoreactivity in the ONL and INL scored against DAPI (mean = 90% ± 7% ONL versus 3% ± 0.4% INL, n = 3 in-
dependent organoids; mean ± SD).
(E) ICC co-staining RP2 with cone arrestin or rhodopsin showing AAV-driven RP2 expression in both rod and cone photoreceptors. Scale
bar, 10 mm.
(F) qPCR of RP2 mRNA transcript levels in AAV-transduced RP2 KO organoids relative to endogenous expression in control organoids (n = 3
independent organoids; mean = 55-fold ±7.7 SEM).
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recoverin and Bassoon (Figure 5A). Measurement of the
ONL revealed that AAV-RP2-transduced RP2 KO organoids
had a significantly thicker ONL than non-transduced con-
trols at D180 (p% 0.01, Figure 5B) with increased numbers
of photoreceptors (Figure S5). The ONL thickness post-
transduction was similar to that observed for the isogenic
control cells at D180, suggesting near complete rescue. In
most, but not all, transduced organoids the percentage of
rhodopsin-positive cells was above the average for non-
transduced RP2 KOs suggesting that AAV RP2 expression
could restore rhodopsin immunoreactivity (Figure 5D).
This was also observed at the mRNA level, with up to a
3-fold increase in RHO level in transduced ROs; however,
one transduced RO showed no response at the level
of rhodopsin expression (Figure 5E). The percentage of
cone arrestin-positive cells was also reduced following
AAV transduction, but ARR3 mRNA was unchanged
(Figure S5).
DISCUSSION
Here, we describe an in vitro model of RP2 XLRP and show
that AAV gene augmentation of RP2 can successfully
reverse measurable and clinically relevant disease pheno-
types. The combination of iPSC reprogramming, CRISPR
gene-editing technology, and AAV gene delivery has
enabled a side by side comparison of RP2 KO, isogenic con-
trols, and XLRP patient ROs, to obviate some of the
inherent variation in iPSC-derived organoid models.
Differentiation of iPSCs presents an opportunity to probe
genetic disease mechanisms in the cells and tissues that are
affected by specific genetic changes. This is particularly use-
ful in the case of ubiquitously expressed genes, such as RP2,
that have disease pathology restricted to a specific tissue,
such as the retina. Here, we used iPSC reprogramming tech-
nology in combination with CRISPR/Cas9 gene editing to
probe disease mechanisms in RP2 XLRP.
All of the RP2-deficient cell lines used in this study suc-
cessfully developed 3D ROs with advanced morphological
features, including lamination and formation of rod and
cone photoreceptors. Strikingly, we observed a significant
decline in photoreceptor cell numbers, specifically
rhodopsin-positive rods, and significantly thinner ONL
after 150 days of differentiation in all RP2-deficient
lines. Widespread rhodopsin expression is one of the later
events in RO development, in keeping with the develop-
mental time line in vivo; however, the presence of other
late-emerging cell markers in the RP2 KO and patient cell
lines, such as cone arrestin-positive cone photoreceptors,
PKCa-positive bipolar cells, and OS structures, together
with the persistence of this rhodopsin-deficient phenotype
up to 300 days of differentiation suggests that this is not
merely a case of developmental delay.
This phenotype has not been reported in any existing an-
imalmodels of RP2XLRP (Li et al., 2013; Zhang et al., 2015),
Figure 5. AAV2/5-Driven RP2 Overex-
pression Rescues Photoreceptor Survival
(A) ICC of retinal organoid ONL with recov-
erin (green) and Bassoon (red) in RP2 KO
control and AAV RP2-treated retinal orga-
noids showing improved ONL thickness in
the AAV-treated group. Scale bar, 10 mm.
(B) Quantification of ONL thickness in con-
trol and AAV transduced retinal organoids
(n = 5 RP2-KO, 6 RP2 KO + AAV independent
organoids, *p = 0.016, mean ± SEM). Dotted
line represents mean thickness in isogenic
control parent cell line.
(C) ICC showing RP2 (green) and rhodopsin
(red) expression after transduction. Scale
bar, 50 mm.
(D) Quantification of ICC to assess rhodopsin-
positive cells in control and RP2 AAV-trans-
duced RP2 KO retinal organoids. Dotted line
represents average control values (n = 5 RP2
KO, n = 6 RP2 KO + RP2 AAV independent
organoids, p = 0.23; mean ± SEM).
(E) qPCR for RHO mRNA levels in control
and RP2 AAV-treated RP2 KO retinal orga-
noids (n = 3 independent organoids).
Mean ± SEM.
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suggesting that this is either specific to human retina, or to
the in vitro organoid system. Despite the relative stability of
ROs in comparison with ex vivo retinal explant culture,
which can be maintained for around 14 days (Johnson
andMartin, 2008), it is likely that the conditions for retinal
cell maintenance in culture are suboptimal. The absence of
an opposing RPEmonolayer, nutrient and oxygen depriva-
tion through the lack of vascular blood supply, or the lack of
connectivity for the inner retinal neurons, for example,
may be sources of stress that accelerate the onset of disease
phenotypes. This may go some way to explain the early
‘‘age’’ of detectable changes relative to mouse and human
RP2 XLRP in vivo. In RP2 KOmice, ONL thinning is detect-
able only at 5 months of age in one model (Li et al., 2013),
whereas almost no ONL thinning was observed at
12 months of age in another model (Zhang et al., 2015).
Here, we detected measurable differences in photoreceptor
survival at the onset of rod differentiation and rhodopsin
expression. Cell death is an important, non-pathological
process during retinal development (Vecino et al., 2004),
but is increased during differentiation in the photoreceptor
cell layer of RP2-deficient ROs, linking rod maturation
temporally with rod cell death in this model. Interestingly,
ROs from an individual with amutation in RPGR, the other
major formofXLRP, also showed signs of photoreceptor cell
death at around 150 days of RO differentiation, which was
rescued by CRISPR-mediated repair of the RPGR mutation
in the iPSC (Deng et al., 2018). The induction of p53 path-
ways was also observed in the RPGR retinal organoidmodel
(Deng et al., 2018), suggesting that this could be a common
pathway in both forms of XLRP in human ROs. Therefore,
photoreceptor cell death appears to be a feature in ROs for
some forms of inherited retinal disease, but the precise
mechanisms andwhether there is an opportunity to inhibit
the cell death process will require further investigation.
AAV is a highly efficient method of delivering therapeu-
tic genes to photoreceptor cells and AAV2/5 has been
shown to effectively transduce photoreceptors in a variety
of species inter alia mice (Palfi et al., 2012), non-human
primates (Boye et al., 2012), and human retinal explants
(Wiley et al., 2018). The use of AAV in human ROs is
currently limited, but studies have reported varying effi-
ciency of transduction, which could be attributed to age
of treatment, time of harvesting, vector tropisms, viral titer,
the promotor used, and the sensitivity of detection of the
transgene, e.g., antibody versus intrinsic fluorescence of a
reporter (Garita-Hernandez et al., 2020; Gonzalez-Cordero
et al., 2018; Quinn et al., 2019). Here, we demonstrate
highly efficient transduction using an AAV2/5 vector
with RP2 under the control of a CAG promoter. The AAV
appears to deliver RP2 more or less exclusively to the
photoreceptor cells despite the use of a ubiquitous promo-
tor. This may be due to a combination of vector tropisms
and the organization of the organoid, where the photore-
ceptor layer is outermost and, therefore, in contact the viral
particles in solution. In addition, the OLM may prevent
diffusion of AAV into the inner retinal layers. The interac-
tion of AAVand photoreceptors in this system is analogous
to the situation following subretinal delivery. Indeed, in
a human treatment context, the optimal route of adminis-
tration for this vector would be subretinal injection.
Although intravitreal injection is less invasive, most AAV
serotypes cannot transduce photoreceptors efficiently
when administered intravitreally.
AAV RP2 was delivered at D140, before the onset of the
increase in photoreceptor TUNEL reactivity and ONL thin-
ning, but late enough to ensure efficient uptake, following
reports of inefficient transduction at earlier time points
(Gonzalez-Cordero et al., 2018). Not only was RP2 effi-
ciently expressed at the mRNA and protein level, but it
was also able to rescue the ONL-thinning phenotype in
RP2 KO ROs implying a protective effect of RP2 overexpres-
sion in photoreceptor cells. Interestingly, although RP2
was expressed at over 55-fold the endogenous level, we
did not observe any overt deleterious effects. In a previous
study, some toxicity was observed with RP2 overexpression
in mice 3 months after administration of the highest
dose of AAV-RP2 vector (1 3 109 viral genomes [vg]/eye),
although the level of RP2 overexpression in transduced
mouse eyes was not defined (Mookherjee et al., 2015). As
RP2 is a GAP for ARL3, it is possible that increasing RP2
to a high level would inhibit the production of ARL3-GTP
and mimic the effect of loss of the ARL3 GEF, ARL13b,
which causes Joubert syndrome; however, this might not
occur in the cellular context because of the spatial separa-
tion of the proteins, with RP2 predominantly at the base
of the cilium and ARL13b in the axoneme, which leads to
a gradient of ARL3-GTP in the cilium. Despite very high
levels of RP2, once ARL3 is trafficked into the cilium it
can be converted to ARL3-GTP by ARL13b; however, this
would not exclude other activities of overexpressed RP2
from disrupting homeostasis. Therefore, additional studies
evaluating the therapeutic index for AAV-RP2 therapies in
ROs, and/or the primate eye, would be of value, before
translation to the clinic.
Although RP2 is expressed in multiple retinal cell types,
it remains to be established whether optimal rescue of the
RP2 disease phenotype may require expression of a
replacement RP2 gene in other retinal cell types, such as
the RPE. The use of a ubiquitous promoter in the current
study should, in principle, enable expression of the thera-
peutic gene in multiple cell types. Additional studies will
be required to fully elucidate the requirement, or other-
wise, for RP2 in the RPE, to develop optimal RP2 gene ther-
apies. In contrast to the current study, Mookherjee et al.
(2015) used the photoreceptor-specific rhodopsin kinase
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promoter to drive expression of the RP2 gene and
achieved a partial rescue of the cone phenotype in a null
RP2 mouse model but had no beneficial effect on the
rod phenotype.
This study provides insights into the use of ROs for
retinal disease modeling, with a phenotype related to loss
of RP2 that is unique to the human retina cell culture
model. Importantly, the photoreceptor cell death in the
RP2-deficient organoids correlates with the timing of rod
cell maturation and rhodopsin expression. Furthermore,
we highlight how the use of AAV for the restoration of
RP2 expression can reverse this phenotype, and as such
could be further investigated as a potential therapeutic
avenue for the treatment of XLRP.
EXPERIMENTAL PROCEDURES
Reprogramming and Gene Editing
Following informed consent, a skin biopsy was obtained from
study participants to obtain dermal fibroblasts. The study fol-
lowed the tenets of the Declaration of Helsinki and was
approved by the Moorfields Eye Hospital and Royal Victoria
Eye and Ear Hospital Dublin Research Ethics Committees. iPSCs
were generated from two unrelated R120X individuals and con-
trol fibroblasts (BJ fibroblast ATCC CRL-2522) as described pre-
viously (Schwarz et al., 2015). RP2 KO iPSCs were produced by
simultaneous reprogramming and gene editing using a method
described previously (Howden et al., 2015). Guide RNAs were
designed to target exon 2 of RP2 (see Table S1 for sequences),
and were cloned into the pSpCas9(BB)-2A-Puro (PX459) V2.0
plasmid (Addgene plasmid no. 62,988) according to a previously
described protocol (Ran et al., 2013). iPSC clones were manually
isolated, genomic DNA extracted (Promega), and PCR amplified
with primers designed around the target site (Table S1). iPSC
clones were analyzed by Sanger sequencing to confirm RP2
gene disruption. Off-Spotter (https://cm.jefferson.edu/
Off-Spotter/) was used to predict off-targets for the selected
gRNA and the top 10 off-targets were assessed with Sanger
sequencing, which detected no changes (Figure S1D; Table S1).
In addition, all DE genes from the RNA-seq analysis were
cross-referenced with off-target predictions and a further eight
potential off-target sites with four or five mismatches were
analyzed (Figure S1E; Table S1). These showed no sequence
changes.
Differentiation of iPSCs to ROs
RO differentiation was carried out as described previously (Na-
kano et al., 2012; Zhong et al., 2014). In brief, iPSCs were grown
to near confluence in E8 medium before detaching colonies in
gentle dissociation buffer (STEMCELL Technologies) to form
embryoid bodies (EBs). EBs were transitioned to neural induc-
tion medium in the presence of blebbistatin, before plating
down at a density of approximately 20 EBs per cm2. Emerging
transparent pouches of neuroepithelium were isolated using a
needle and cultured in suspension in retinal maturation
media +0.5 mm retinoic acid up to D140, after which retinoic
acid was removed. Alternatively EBs were generated by single-
cell dissociation and forced aggregation in 96-well V-bottomed
plates and cultured in suspension thereafter (Nakano et al.,
2012). Days of culture are ±3days.
AAV Production
The RP2 replacement vector comprising a CAG promoter, human
RP2 CDS, RP2 30 UTR, including an RP2 poly(A) sequence, and a
minimal rabbit b-globin poly(A), was synthesized by GeneArt
(Life Technologies) and cloned into pAAV-MCS using flanking
NotI sites. More detail of sequences is in the Supplemental Infor-
mation. Recombinant AAV2/5 viruses were generated by helper vi-
rus-free, triple transfection (Xiao et al., 1998). Human embryonic
kidney cells (accession number CRL-1573; ATCC, USA) were trans-
fected with pAAV-RP2, pRep/Cap5 (Hildinger et al., 2001) and
pHelper (Agilent Technologies, USA) at a ratio of 1:1:2, as described
previously (O’reilly et al., 2007). Seventy-two hours after transfec-
tion, AAV particles were purified from the clarified lysate by differ-
ential precipitation with polyethylene glycol followed by cesium
gradient centrifugation (Ayuso et al., 2010). AAV-containing frac-
tions were dialyzed against PBS supplemented with Pluronic F68
(0.001%; Bennicelli et al., 2008). Genomic titers (vg/mL) were
determined by quantitative real-time PCR (qPCR; Rohr et al.,
2002).
AAV Treatment
RP2 AAV was prepared to a final titer 4.73 3 1012 vg/mL. At
140 days, organoids with brush borders visible by light micro-
scopy, which show inner segment and OS development, were
transferred to the well of 96-well plate and incubated with 1E11
viral genomes in 75 mL media for 8 h before topping the media
up to 200 mL. Followed by 50/50 medium changes every 2 days
until day 180.
RNA Extraction and qPCR
ROs or half ROs were subjected to RNA extraction using an RNeasy
MicroKit (QIAGEN) and cDNA synthesis was performed using a
Tetro cDNA synthesis kit (Bioline). qPCR was carried out on an
Applied Biosystems 7900HT Fast Real-Time PCR system using the
SYBR Green method using 1 mL cDNA per triplicate. Data from
the qPCR were normalized to the geometric mean of the expres-
sion of two internal reference genes in each sample. POLR2A and
MAN1B1 were chosen due to their consistency across the sample
groups, which was determined using the GeNorm algorithm (Van-
desompele et al., 2002). Primers were designed to cross exon
boundaries (see Table S2).
RNA-Seq
Three ROs from BJ controls and R120X cell lines and two ROs from
the RP2 KO cell line were harvested at D150. The RNA was ex-
tracted with the RNeasy micro kit (QIAGEN) following the manu-
facturer’s instructions, followed by paired-end sequencing at 100
million read depth for each sample (Illumina, Otogenetics, At-
lanta, GA, USA). Raw.fastq sequences were cleaned from any resid-
ual sequencing adapter using cutadapt with parameters -m 20
and -e 0.1. Fragments were then aligned to the human genome
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(build 38, Ensembl version 92) using STAR and genes counted us-
ing featurecounts.
Differential expression analysis was then performed using the
DESeq2 pipeline. Initial inspection of the dataset showed biases,
which were blind estimated and corrected using the sva package
(DESeq2 manual). The differential expression analysis showed
that 1,141 genes were differentially expressed between the
R120X ROs and the control, whereas 979 genes were differentially
expressed between the RP2 KO ROs and the isogenic control and
328 genes were common to the 2 RP2-depleted backgrounds. Of
these, 232 genes were consistently upregulated and 56 were down-
regulated. The list of DE genes is shown in Table S3. Finally,
we used the web platform Enricher to source any significant
pathway (https://amp.pharm.mssm.edu/Enrichr/). According to
the KEGG there was a significant upregulation of the ‘‘p53
signaling pathway’’ in the RP2 KO and RP2-R120X retina
(Figure S3).
Immunofluorescence
ROs were either fixed whole or bisected under a dissecting micro-
scope using micro scissors (Fine Science Tools) with the other
half processed for RNA extraction. ROs or half ROs were fixed in
4% paraformaldehyde at 4!C for 20–30 min before cryoprotection
by immersion overnight in 30% sucrose/PBS. Following orienta-
tion under a dissecting microscope in OCT they were frozen and
cryosectioned into 6-mm sections. For ICC, slides were blocked in
10% donkey serum, 0.1% Triton X for 1 h before incubation
with primary antibodies for 2 h (see Table S4 for primary anti-
bodies) and donkey anti-rabbit or mouse Alexa Flour 488 or 555
secondary antibodies for 1 h (Thermo Fisher). Nuclei were visual-
ized using DAPI (2 mg/mL) staining for all images.
Imaging
All images were obtained using a Carl Zeiss LSM700 or LSM 710
laser scanning confocal microscope. Images were exported from
Zen imaging software and prepared using Adobe Photoshop and
Illustrator CS4. All measurements were performed in Fiji (Schinde-
lin et al., 2012). For quantification of TUNEL, rod and cone cell
numbers, and ONL thickness measurements, the tilescan function
was used to obtain images of whole organoid sections at 403
magnification (more detail in Supplemental Information). Individ-
ual rod-, cone-, and TUNEL-positive cell numbers in the ONL were
manually counted across the whole section. ONL thickness was
calculated by measuring the length and area of the whole recov-
erin-positive ONL in the DAPI channel using Fiji.
Electron Microscopy
ROs were fixed overnight in 3% glutaraldehyde and 1% parafor-
maldehyde buffered to pH 7.4 with 0.08 M sodium cacodylate-
HCl buffer. After rinsing in 0.1 M sodium cacodylate-HCl buffer
(pH 7.4) twice for 5 min, the ROs were post-fixed in 1% aqueous
osmium tetroxide for 2 h, dehydrated by passage through
ascending alcohols (10-min steps, 13 50%–90% and 3% 3
100%) and two changes of propylene oxide, and infiltrated over-
night with a 1:1 mixture of propylene oxide:araldite on a rotator.
Finally, ROs were infiltrated with araldite resin over 4–6 h and
embedded in fresh resin, which was then cured by overnight
incubation at 60!C. Semithin sections (0.75 mm) were stained
with a 1% mixture of toluidine blue-borax in 50% ethanol, and
ultrathin sections were contrasted with Reynolds lead citrate for
imaging in a JEOL 1010 TEM operating at 80 kV. Images were
captured using a Gatan Orius CCD camera using Digital Micro-
graph software.
Statistical Analysis
Statistical analysis was carried out on GraphPad Prism. Data were
subjected to two-way ANOVA and/or by multiple t tests using
the Holm-Sidak method, with a = 5.00%. Each time point was
analyzed individually, without assuming a consistent standard de-
viation (SD). Significance was determined at a p value of < 0.05.
Data and Code Availability
The RNA-seq data are available at GEO: GSE148300.
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